1346 mTFF2-MSA (mTNX-1700) suppresses tumor growth in an Anti-PD-1 treated Pan02 syngeneic pancreatic cancer model by targeting MDSCs in C57BL/6 Mice

Documenti analoghi

• 1346 mTFF2-MSA (mTNX-1700) suppresses tumor growth in an Anti-PD-1 treated Pan02 syngeneic pancreatic cancer model by targeting MDSCs in C57BL/6 Mice
  di: Grace Zhao, et al.
  Pubblicazione: (2023-11-01)
• Tumor-immune profiling of CT-26 and Colon 26 syngeneic mouse models reveals mechanism of anti-PD-1 response
  di: Yosuke Sato, et al.
  Pubblicazione: (2021-11-01)
• Comparison of cisplatin-induced anti-tumor response in CT26 syngeneic tumors of three BALB/c substrains
  di: Jeong Eun Gong, et al.
  Pubblicazione: (2021-12-01)
• Enhanced Antitumor Effect of Oncolytic Virotherapy Combined with mRNA-Encoded Immunoadjuvants in Colorectal Carcinoma (CT26) Tumor Model
  di: Anastasia Ryapolova, et al.
  Pubblicazione: (2025-12-01)
• Towards reliable hyperspectral imaging biomarkers of CT26 murine tumor model
  di: Tadej Tomanic, et al.
  Pubblicazione: (2024-11-01)